Cargando…

Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial

INTRODUCTION: Multimodality therapy, including preoperative chemoradiotherapy (CRT) and total mesorectal excision (TME), has effectively reduced local recurrence rates of rectal cancer over the past decade. However, the benefits and risks of the addition of neoadjuvant CRT to surgery need to be eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Wen-Hua, Wang, Fu-Long, Lu, Zhen-Hai, Pan, Zhi-Zhong, Li, Li-Ren, Gao, Yuan-Hong, Chen, Gong, Wu, Xiao-Jun, Ding, Pei-Rong, Zeng, Zhi-Fan, Wan, De-Sen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593338/ https://www.ncbi.nlm.nih.gov/pubmed/26111932 http://dx.doi.org/10.1186/s40880-015-0024-8

Ejemplares similares

Preoperative chemoradiotherapy creates an opportunity to perform sphincter preserving resection for low-lying locally advanced rectal cancer based on an oncologic outcome study
por: Lin, Jun-Zhong, et al.
Publicado: (2016)

Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial
por: Wang, Fulong, et al.
Publicado: (2018)

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis
por: Lee, Jeong Won, et al.
Publicado: (2013)

Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer
por: Zhang, Shu, et al.
Publicado: (2021)

High dose chemoradiotherapy increases chance of organ preservation with satisfactory functional outcome for rectal cancer
por: Wang, Qiao-Xuan, et al.
Publicado: (2022)

Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer
por: Qiu, Bo, et al.
Publicado: (2016)

Pathological Assessment of the AJCC Tumor Regression Grading System After Preoperative Chemoradiotherapy for Chinese Locally Advanced Rectal Cancer
por: Zhang, Lu-Ning, et al.
Publicado: (2016)

Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy
por: Chou, Chia-Lin, et al.
Publicado: (2022)

Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients
por: Zhang, Rong-xin, et al.
Publicado: (2017)

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors
por: Kong, Moonkyoo, et al.
Publicado: (2012)

Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer
por: Wu, Fengpeng, et al.
Publicado: (2020)

Utility of RGNEF in the Prediction of Clinical Prognosis in Patients with Rectal Cancer Receiving Preoperative Concurrent Chemoradiotherapy
por: Chen, Chih-I., et al.
Publicado: (2021)

HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer
por: Huang, Yi-Jung, et al.
Publicado: (2022)

Impact of circumferential tumor location of mid to low rectal cancer on oncologic outcomes after preoperative chemoradiotherapy
por: Park, Hyeong-min, et al.
Publicado: (2022)

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer
por: Gao, Jiale, et al.
Publicado: (2023)

Concurrent chemoradiotherapy plus anlotinib vs. concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: An interim analysis of a multicenter randomized controlled trial
por: Chen, Kequan, et al.
Publicado: (2023)

Neoadjuvant therapy of metformin is associated with good tumor response after preoperative concurrent chemoradiotherapy for rectal cancer
por: Han, Jeonghee, et al.
Publicado: (2022)

Tumor compactness improves the preoperative volumetry-based prediction of the pathological complete response of rectal cancer after preoperative concurrent chemoradiotherapy
por: Hsu, Che-Yu, et al.
Publicado: (2016)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Systematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer
por: Zheng, Jiabin, et al.
Publicado: (2017)

Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy
por: Lee, Yi-Ying, et al.
Publicado: (2017)

Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience
por: Choi, Euncheol, et al.
Publicado: (2016)

Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer
por: Zhang, Jin-Liang, et al.
Publicado: (2017)

A review of preoperative chemoradiotherapy for lower rectal cancer
por: Beppu, Naohito, et al.
Publicado: (2018)

Volumetric imaging parameters are significant for predicting the pathological complete response of preoperative concurrent chemoradiotherapy in local advanced rectal cancer
por: Wu, Fengpeng, et al.
Publicado: (2019)

Patterns of recurrence in patients achieving pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer
por: Fan, Wen-Hua, et al.
Publicado: (2017)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
por: Wang, Qiao-xuan, et al.
Publicado: (2021)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
por: Yang, Zhi, et al.
Publicado: (2023)

Knowledge, Attitudes, and Practices Related to Preoperative Chemoradiotherapy in Rectal Cancer Patients
por: Chen, Xingxing, et al.
Publicado: (2016)

Impact of preoperative chemoradiotherapy using concurrent S-1 and CPT-11 on long-term clinical outcomes in locally advanced rectal cancer
por: Kimura, Kei, et al.
Publicado: (2020)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
por: Lee, Hong Seok, et al.
Publicado: (2016)

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer
por: De Felice, Francesca, et al.
Publicado: (2013)

Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients
por: Yasui, Kazuaki, et al.
Publicado: (2020)

Organ preservation for early rectal cancer using preoperative chemoradiotherapy
por: Son, Gyung Mo
Publicado: (2023)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
por: Guo, Su-ping, et al.
Publicado: (2021)

Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study
por: Peng, Jianhong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p0do0f2g2cavibt4edqhen72v8